|Articles|October 14, 2022
- Applied Clinical Trials-10-01-2022
- Volume 31
- Issue 10
Applied Clinical Trials October 2022 Issue (PDF)
Advertisement
Articles in this issue
almost 4 years ago
Managing Biospecimens in Cell and Gene Therapy Trialsalmost 4 years ago
The Risk-Reward Proposition for CGT Clinical Trialsalmost 4 years ago
Philadelphia Shines in Cell and Gene Therapy Research Pursuitsalmost 4 years ago
Survey Investigates Backup Solution Adoption for ePRO Systemsalmost 4 years ago
Scientists Don’t Ever Stop Sciencingalmost 4 years ago
Key Clinical Trial Industry Themes Post-COVIDAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
4
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
5
